In early 2021, CDC awarded states another round of Epidemiology and Laboratory Capacity (ELC) COVID-19 Enhancing Detection funds as part of the Coronavirus Response and Relief Supplemental Appropriations Act of 2021. The purpose of this funding is to prevent, prepare, and respond to COVID-19 by supporting testing, case investigation and contact tracing, surveillance, containment, and mitigation. These funds (referred to as ELC round 2, 2.1, and 2.2) build upon the ELC Enhancing Detection funds provided to LPHAs in June 2020 (referred to as ELC round 1).
CFDA#.
93.323 - Epidemiological and Laboratory Capacity for Infectious Diseases (ELC).
Subrecipients shall comply with the requirements applicable to the federal program. This includes OMB Circular A-133 and/or Uniform Grant Guidance.
Who is this grant for?
Local Public Health Agencies.
Personnel to perform critical containment activities, such as disease surveillance, case investigation, contact tracing, and testing, based on jurisdictional needs.
The project also supports local responses to COVID-19 outbreaks, infection prevention efforts at health care and other settings, and promotes health equity aspects of the response.
What is the funding period?
August 1, 2024 - July 31, 2025.
The Standard Invoice Form will be used for ELC 2.1.
The Contractor shall submit the Program Plan (including Surge, Testing, and Transition Plans) via email to the CDPHE Contract Monitor. Template Located Here.
No later than 45 days after the execution of the contract.
The Contractor shall report COVID-19 outbreaks prioritized for investigation in EpiTrax or other approved CDPHE system.
Within 1 working day of identifying the outbreak or as defined in updated CDPHE guidance.
The Contractor shall submit final outbreak report forms in EpiTrax or other approved CDPHE system
Within 2 weeks of the outbreak meeting closure criteria.
The Contractor shall notify the CDPHE Contract Monitor via email of unobligated funds.
At any time during the contract period upon request from CDPHE.
The Contractor shall respond to a quarterly survey to report progress toward achieving response activities outlined in this SOW, via form submission at the following link. Quarterly Progress Report Here.
No later than 45 days after each reporting quarter, to coincide with monthly submission of invoices.
What are allowable costs?
Indirect costs will be approved based on the current approved negotiated indirect cost rate agreement.
Because overtime costs are a very likely and reasonable expense during the response to COVID-19, CDC will allow recipients to include projected overtime in their budgets. Recipients should be careful to estimate costs based on current real-time needs and will still be required to follow federal rules and regulations in accounting for the employee's time and effort.
What are unallowable costs?
Research.
Clinical care except as provided above in connection with Domain 4 (testing) activities.
Publicity and propaganda (lobbying) other than for normal and recognized executive-legislative relationships, no funds may be used for:
Publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body.
All unallowable costs cited in CDC-RFA-CK19-1904 remain in effect, unless specifically amended in this guidance, in accordance with 45 CFR Part 75 – Uniform Administrative Requirements, Cost Principles, And Audit Requirements for HHS Awards.
Can I purchase food and refreshments for staff?
No, food purchases for staff are unallowable.
Can gift cards or cash incentives be purchased with this funding?
No, incentives are not allowable.
Can additional pay be provided to staff retroactively based on new agency policy?
No, per 2 CFR 200.430(f) and 45 CFR 75.430(f) compensation must be "pursuant to an agreement entered into in good faith between the non-Federal entity and the employees before the services were rendered". This means that the pay rate must be established prior to the work or services being done. New policies can only impact pay practices moving forward and must be consistently applied across all funding sources, Federal and non-Federal.
ELC 2.2 Expense Allowability Roadmap Link Here.
ELC COVID-19 Quarantine & Isolation Support Costs guidance document (updated 9/8/23) Link Here.
Link to Email Post Award Email Communication (Pending).
CDC Guidance (approved).
ELC ENHANCING DETECTION THROUGH CORONAVIRUS RESPONSE AND RELIEF (CRR) SUPPLEMENTAL FUNDS (approved).
Media Disclosure - Memo (added 6/30/21).